标题
Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 10, Pages e111302
出版商
Public Library of Science (PLoS)
发表日期
2014-10-22
DOI
10.1371/journal.pone.0111302
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression
- (2014) Victoria Male et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow
- (2014) Cécile Daussy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Direct Action of Type I IFN on NK Cells Is Required for Their Activation in Response to Vaccinia Viral Infection In Vivo
- (2014) J. Martinez et al. JOURNAL OF IMMUNOLOGY
- Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
- (2014) Dorothy K Sojka et al. eLife
- Beyond NK Cells: The Expanding Universe of Innate Lymphoid Cells
- (2014) Marina Cella et al. Frontiers in Immunology
- Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
- (2013) Hui Peng et al. JOURNAL OF CLINICAL INVESTIGATION
- Taming the Beast within: Regulation of Innate Lymphoid Cell Homeostasis and Function
- (2013) W. Xu et al. JOURNAL OF IMMUNOLOGY
- Location and cellular stages of natural killer cell development
- (2013) Jianhua Yu et al. TRENDS IN IMMUNOLOGY
- Regulation of murine natural killer cell commitment
- (2013) Nicholas D. Huntington et al. Frontiers in Immunology
- Mouse natural killer cell development and maturation are differentially regulated by SHIP-1
- (2012) C. Banh et al. BLOOD
- Differential Responses of Immune Cells to Type I Interferon Contribute to Host Resistance to Viral Infection
- (2012) Thomas Baranek et al. Cell Host & Microbe
- Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
- (2012) Tatsuaki Mizutani et al. OncoImmunology
- Identification of the earliest NK-cell precursor in the mouse BM
- (2011) S. Carotta et al. BLOOD
- Identification of the earliest natural killer cell-committed progenitor in murine bone marrow
- (2011) J. W. Fathman et al. BLOOD
- Transcriptional control of natural killer cell differentiation and function
- (2011) Alfonso Martín-Fontecha et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection
- (2011) Navkiran Gill et al. CELLULAR IMMUNOLOGY
- Cutting Edge: A Dual Role for Type I IFNs during Polyinosinic-Polycytidylic Acid-Induced NK Cell Activation
- (2011) H. Beuneu et al. JOURNAL OF IMMUNOLOGY
- Salivary Gland NK Cells Are Phenotypically and Functionally Unique
- (2011) Marlowe S. Tessmer et al. PLoS Pathogens
- Type I interferon: friend or foe?
- (2010) Giorgio Trinchieri JOURNAL OF EXPERIMENTAL MEDICINE
- Maturation of mouse NK cells is a 4-stage developmental program
- (2009) L. Chiossone et al. BLOOD
- Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo
- (2009) Shintaro Kamizono et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ly49H Engagement Compensates for the Absence of Type I Interferon Signaling in Stimulating NK Cell Proliferation During Murine Cytomegalovirus Infection
- (2009) T. L. Geurs et al. JOURNAL OF IMMUNOLOGY
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
- (2009) Duncan M Gascoyne et al. NATURE IMMUNOLOGY
- Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon–dependent exhaustion
- (2009) Taku Sato et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now